Concepedia

Author

Rosa Ayala

Hospital Universitario 12 De OctubreORCID

Also Known As

Antonio Valeri, Ayala, Rosa, C. Puckett, Dolors Costa, Manuel Fernández‐Delgado, Natàlia Estrada, R Ayala, R. AYALA, R. Ayala, R. Ayala Diaz

330

Publications

3.2K

Citations

29

H-Index

72

Concepts

All Affiliations

Hospital Universitario 12 De OctubreCentro de Investigación Biomédica en Red de CáncerUniversidad Complutense de MadridResearch Institute Hospital 12 de OctubreHospital Universitario Ramón y Cajal
RA

About

Rosa Ayala is an author at Hospital Universitario 12 De Octubre specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

19

772

2

Health Sciences

5

5

146

3

Public Health

3

3

81

4

Engineering

2

2

80

5

Natural Sciences

1

1

49

Rosa Ayala

×

63

Publications

2.5K

Citations

28

H-Index

YearCitations

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Joaquín Martínez‐López, Juan José Lahuerta, François Pépin,

Blood

2014

424

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi,

The Lancet

2023

164

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Juliane Menezes, Francesco Acquadro, Michele S. Wiseman,

Leukemia

2013

161

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli,

Haematologica

2016

145

Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies

José María Sánchez‐Pina, Mario Rodríguez, Nerea Castro Quismondo,

European Journal Of Haematology

2020

90

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Eva Barragán, Pau Montesinos, Mireia Camós,

Haematologica

2011

63

Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients

Rosa Ayala, Silvia Grande, Rosalía Bustelos,

BMC Gastroenterology

2012

59

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response

Pilar Martínez‐Sánchez, Laura Montejano, María Eugenia Sarasquete,

British Journal of Haematology

2008

58

Impact of COVID-19 in patients with multiple myeloma based on a global data network

Joaquín Martínez‐López, Gema Hernández, R. Alonso,

Blood Cancer Journal

2021

56

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

Joaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio,

Leukemia

2017

50

Page 1